![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Oxford Performance Materials’ OsteoFab Technology Granted European Patent for 3D Printed Implants
Oxford Performance Materials’ OsteoFab Technology Granted European Patent for 3D Printed Implants
March 13, 2017
Oxford Performance Materials has received a Notice of Decision to Grant a Patent from the European Patent Office for the company’s invention, which leverages its OsteoFab implant manufacturing process.
The patent protects the company’s OsteoFab process for manufacturing a three-dimensional object from poly-ether-ketone-ketone powders using a laser.
The patent will be valid until August 7, 2029. — Cynthia Jessup
Upcoming Events
-
21Oct